Article citationsMore>>

Foster, S.L., Woolsey, C., Borisevich, V., Agans, K.N., Prasad, A.N., Deer, D.J., Geisbert, J.B., Dobias, N.S., Fenton, K.A., Cross, R.W. and Geisbert, T.W. (2022) A Recombinant VSV-Vectored Vaccine Rapidly Protects Nonhuman Primates against Lethal Nipah Virus Disease. Proceedings of the National Academy of Sciences of the United States of America, 119, e2200065119.
https://doi.org/10.1073/pnas.2200065119

has been cited by the following article:

• TITLE: Nipah Virus: A Zoonotic Virus Transmitted from Bats and Pigs, Causing an Epidemic in Southeast Asia

  AUTHORS: Hongting Lin

  KEYWORDS: Nipah Virus, Zoonotic Transmission, Ephrin-B2, Ephrin-B3, Viral Outbreaks, Clinical Outcomes, Animal Reservoir

  JOURNAL NAME: Advances in Infectious Diseases, Vol.13 No.2, June 14, 2023

  ABSTRACT: Nipah Virus (NiV), a member of the Paramyxoviridae family, is one of the most infectious zoonotic viruses in Southeast Asia. First recorded in Malaysia in 1998, the NiV outbreak infected hundreds of people, with an almost 50% death rate. The virus is transmitted through direct contact with contaminated subjects and infecting the human respiratory system. Ephrin B2 and B3, the surface glycoproteins on the host cell, have been the primary and the most effective route for viral entrance. Binding with viral surface G protein, the F protein triggers, enabling viral-host fusion. Until now, NiV vaccines are not yet available in the public market, however, preventions such as avoiding direct contact and masking are advised.